KBC Group NV Sells 16,156 Shares of Thermo Fisher Scientific Inc. (TMO)

KBC Group NV trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 9.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 149,671 shares of the medical research company’s stock after selling 16,156 shares during the quarter. KBC Group NV’s holdings in Thermo Fisher Scientific were worth $28,318,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in TMO. Covington Capital Management increased its holdings in Thermo Fisher Scientific by 0.9% in the 2nd quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock valued at $374,000 after buying an additional 20 shares during the period. Investment Centers of America Inc. increased its holdings in Thermo Fisher Scientific by 1.6% in the 2nd quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock valued at $230,000 after buying an additional 21 shares during the period. Fort Washington Investment Advisors Inc. OH increased its holdings in Thermo Fisher Scientific by 0.4% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock valued at $1,090,000 after buying an additional 23 shares during the period. Bienville Capital Management LLC increased its holdings in Thermo Fisher Scientific by 1.6% in the 2nd quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock valued at $295,000 after buying an additional 27 shares during the period. Finally, Savant Capital LLC increased its holdings in Thermo Fisher Scientific by 1.0% in the 2nd quarter. Savant Capital LLC now owns 2,793 shares of the medical research company’s stock valued at $487,000 after buying an additional 29 shares during the period. 86.16% of the stock is currently owned by institutional investors and hedge funds.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) traded up $3.97 during trading on Friday, hitting $192.27. 3,850,000 shares of the company traded hands, compared to its average volume of 1,690,000. The company has a market cap of $76,690.00, a price-to-earnings ratio of 21.13, a PEG ratio of 1.76 and a beta of 1.06. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc. has a 12 month low of $139.88 and a 12 month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm’s revenue was up 13.9% on a year-over-year basis. During the same period in the previous year, the firm posted $2.03 EPS. equities research analysts predict that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.19%.

In related news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the sale, the chief executive officer now directly owns 252,577 shares in the company, valued at approximately $47,582,981.03. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.49% of the company’s stock.

Several research firms have commented on TMO. Jefferies Group reissued a “hold” rating and issued a $195.00 target price on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price on the stock in a report on Thursday, September 7th. Leerink Swann reissued an “outperform” rating and issued a $200.00 target price (down from $216.00) on shares of Thermo Fisher Scientific in a report on Monday, December 4th. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, Morgan Stanley reissued an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $205.21.

TRADEMARK VIOLATION NOTICE: This article was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://sportsperspectives.com/2017/12/17/kbc-group-nv-sells-16156-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply